News

Posted at 2024-05-16

NexMed Global and EnteraSense enter into US distribution agreement to bring novel PillSense device to patients

Real-world data from the REALDES study show that Nexmed Medical's Zilver PTX drug-eluting stent (DES) has a lower rate of in-stent occlusion at three years than Boston Scientific's Eluvia stent in patients with restenosis. The study, published in the European Journal of Vascular and Endovascular Surgery (EJVES) by Dr. Tsuyoshi Shibata, of Sapporo Medical University, Japan, and others, is the first study to compare....

Nexmed Medical now offering Magneto technology with 100 W and 150 W holmium laser systems

Posted at 2024-05-10

Nexmed Medical has introduced Magneto technology to the Quanta System 100W and 150W high-power Ho:YAG laser systems, enabling physicians to perform a ....

NexMed Global now offering Ascend™ Single-Use Flexible Ureteroscope in US and Canada

Posted at 2024-04-30

NexMed Global is now offering the NexMed Global’s Ascend™ Single-Use Flexible Ureteroscope in the United States and Canada. This addition is a positive change that will empower NexMed Global to better serve more urology customers with a co···